查找临床试验
已按「骨髓增生异常综合征」检索，对应国际通用词 myelodysplastic syndrome
共找到 63 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 23:04，每 5 分钟自动同步A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
China
年龄 18 Years – 不限
Ascentage Pharma Group Inc.
Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow Cytometry
China
年龄 15 Years – 70 Years
Peking University People's Hospital
A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
China
年龄 18 Years – 75 Years
Ruijin Hospital
A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants
China
年龄 18 Years – 55 Years
Shenzhen Kangzhe Biotechnology Co., Ltd.
Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients
China
年龄 18 Years – 不限
Institute of Hematology & Blood Diseases Hospital, China
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
United States、China
年龄 18 Years – 不限
Akeso
Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS
China
年龄 18 Years – 65 Years
Institute of Hematology & Blood Diseases Hospital, China
Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies
China
年龄 18 Years – 75 Years
Beijing Biotech
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
United States、Australia、China
年龄 18 Years – 不限
Beijing InnoCare Pharma Tech Co., Ltd.
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
United States、Australia、Belgium、Bulgaria、Canada 等 12 国
年龄 18 Years – 不限
Celgene
High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
China
年龄 不限 – 不限
Yigeng Cao,MD,PhD
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
United States、Australia、Brazil、Bulgaria、Canada 等 12 国
年龄 18 Years – 不限
Takeda